explore -WSS

explore

author：knowledge 2025-10-02 19:38:55 - browse：1

prostate cancer cells — Prostate cancer cells seen under the microscope. NIH

Prostate cancer tends to be the tortoise of tumors, growing and spreading slowly. When cancerous cells escape the golf ball-sized prostate, they can lodge in various places throughout the body. New research shows that where these cells go can affect how long a man survives.

When prostate cancer spreads, or metastasizes, about three-quarters of the time it takes up residence in the bones. Less common locations are the lungs, liver, and lymph nodes.

An international team of researchers pooled information from nine clinical trials to estimate the average survival times for men with prostate cancer that had spread to four different tissues. Metastasis to the lymph nodes was linked to the longest survival; metastasis to the liver led to the shortest.

“This important study confirms that one size does not fit all when it comes to metastatic prostate cancer,” said Dr. Marc Garnick, a prostate cancer specialist at Beth Israel Deaconess Medical Center in Boston.

The new study, led by Susan Halabi, a professor of biostatistics at Duke University School of Medicine, suggests that prostate cancer that skips the bones and spreads to the liver and lungs may represent a different disease than prostate cancer that invades bones or lymph nodes. The results were published Monday in the Journal of Clinical Oncology.

Median survival for metastatic prostate cancer is affected by metastasis site. Mark Dubowski for Duke Health

“A better understanding of how metastatic prostate cancer behaves in different locations is letting us tailor diagnostic approaches and treatments that we hope will improve outcomes,” Garnick said.

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Medicare explains how it will choose drugs for negotiation

WSS

Feds fine Medicare Advantage plans for overcharging members

Timeline: Key moments in fight for gay rights

Biogen nominates mother of director’s child to replace him on board

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Eli Lilly’s Mounjaro succeeds in second weight

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

hotspot

explore

focus

Medical records are filled with copy

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Continuity nursing helped my family in our darkest PICU moments

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Tori Bowie and the unacceptable rates of Black maternal death

Novo pauses ads for weight loss drug Wegovy amid demand

Tori Bowie and the unacceptable rates of Black maternal death

Altering the blood type of lungs raises potential for universal organs for transplants

Virginia high school admissions case could be legal follow

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

hotspot

Timeline: Key moments in fight for gay rights

The thinking behind the controversial eating disorder chatbot Tessa

Australia’s approach to dialysis celebrates life

Medicare explains how it will choose drugs for negotiation

How to make Best Hospitals ratings actually useful for patients

Drug firms test therapies to halt Alzheimer’s before symptoms arise

explore

entertainment

hotspot

hotspot